Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Clinical trial NCT04830813 · COMPLETED

Trial details

NCT number: NCT04830813
Sponsor: Chipscreen Biosciences, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2021-03-05
Primary completion: 2024-04-01
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.